The Wellcome Trust invites applications for its seeding drug discovery scheme. This aims to develop drug-like, small molecules that will be the springboard for further research and development by the biotechnology and pharmaceutical industry in areas of unmet medical need. Projects must address an unmet need in healthcare or in applied medical research, offer a potential new solution and have a realistic expectation that the innovation will be developed further by the market.
Early-stage drug discovery projects may request funding for up to two years, while late-stage lead to clinical projects may request up to four years’ funding, to support lead optimisation and preclinical development.
A preliminary application form should be completed and returned to Innovations by the published deadline.
Applications will be considered at one of the two Seeding Drug Discovery Committee meetings in each 12-month period.
Successful applicants will be shortlisted and invited to complete a full application, which is subject to international peer review by members of the Innovations Advisory Group.
Deadline: 5 November
For further information, guidance and to apply please visit the funder’s website.